Satoko Ogita

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients

Yasuhiro Kawai, Naoyuki Miyashita, Mika Kubo et al. · Antimicrobial Agents and Chemotherapy · 2013 · 109 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +17

Nationwide Surveillance of Macrolide-Resistant Mycoplasma pneumoniae Infection in Pediatric Patients

Yasuhiro Kawai, Naoyuki Miyashita, Mika Kubo et al. · Antimicrobial Agents and Chemotherapy · 2013 · 108 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +12

Management of refractory Mycoplasma pneumoniae pneumonia: Utility of measuring serum lactate dehydrogenase level

Norikazu Inamura, Naoyuki Miyashita, Shunji Hasegawa et al. · Journal of Infection and Chemotherapy · 2014 · 104 citations

Veterinary Medicine, Clinical Sciences, Infectious Diseases +13

Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Infection, Japan, 2008–2015

Takaaki Tanaka, Tomohiro Oishi, Ippei Miyata et al. · Emerging infectious diseases · 2017 · 104 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +11